Last month, Japanese biotechnology research was given a huge boost of around ¥80 billion ($680 million) from the Diet (Japan's parliament) to create new biotechnology-oriented business. The Ministry of International Trade and Industry (Tokyo), which will handle ¥60 billion of the funds, will use part of the money to create and market a database holding various genetic information for commercial use. Additionally, The Science and Technology Agency (Tokyo) will receive a total of ¥3.6 billion ($30 million) for brain-sciences and genome-research programs, ¥7.1 billion to support new venture businesses at universities, and ¥13 billion for "commercially applicable research." Some of the money will go to the new genome research center at the Institute of Physical and Chemical Research (Saitama), which opened last October to carry out DNA base sequencing, analysis of the human genome, and the analysis of protein structure and function using nuclear magnetic resonance. The money forms part of the Diet's third supplementary budget totaling ¥24 trillion (US$ 204 billion)—an economic stimulus package aimed at reviving the nation's ailing economy. This budget features ¥4 trillion for a "social infrastructure program" aimed at building the infrastructure required for areas such as science and technology, information technology, and the environment.